rewirebio.iobenchmarks
Evidence and investigation

Contested results

Where one study disagrees with what other studies report for the same models, and what we are doing to resolve each case.

These are automatic leads, not findings of error. Each release, a check compares how every study ranks the models it shares with other studies. It flags a study that reverses the order the others agree on, or whose gap to a shared reference model lies well outside theirs. Different tasks, populations or metrics often explain a flag.

A flag never hides a result. Flagged results stay in every table, page and download, marked Contested. A result is withheld only when a reviewer marks it disputed.

How the check works, and how each follow-up is recorded: discrepancies between studies.

In this release

  • 220open
  • 0settled
  • 1resolved
  • 1high severity
  • 12medium severity
  • 208low severity

Release 2026-10-23-5347695500ed · 221 findings in all · rules version 3

Findings

Status: All · Open · Settled · Resolved

Severity: All · High · Medium · Low

State: All · Not yet reviewed · Confirmed error

Showing findings that compare Nucleotide Transformer v2. All models

2 findings match, most severe first.

Nucleotide Transformer v2 and Evo: GENEB leaderboard (leaderboard.json, 13 task-type aggregates) reverses the order

  • Low severity
  • Not yet reviewed
  • Ordering reversal
  • Different tasks across studies

GENEB leaderboard (leaderboard.json, 13 task-type aggregates) ranks Nucleotide Transformer v2 above Evo in 42 of 45 comparisons; other studies rank Evo above Nucleotide Transformer v2 in 6 of 6.

Zero-shot benchmarking of RNA language… ranks Evo above Nucleotide Transformer v2 in all 6 of its comparisons. GENEB leaderboard ranks Nucleotide Transformer v2 above Evo in 42 of its 45 comparisons and Evo higher in 3.

Comparisons in which each paper scores Evo or Nucleotide Transformer v2 higherZero-shot benchmarking of RNA language…: Evo higher in 6, Nucleotide Transformer v2 higher in 0, 0 ties. GENEB leaderboard (disagrees): Evo higher in 3, Nucleotide Transformer v2 higher in 42, 0 ties.Zero-shot benchmarking of RNA language…6 Evo higher6Disagrees: GENEB leaderboardGENEB leaderboard (leaderboard.json, 13 task-type aggregates)3 Evo higher42 Nucleotide Transformer v2 higher42
Evo higherTieNucleotide Transformer v2 higher
Compared
Nucleotide Transformer v2, Evo

Not reviewed yet.

Nucleotide Transformer v2 and Evo: Zero-shot benchmarking of RNA language models in structural, functional, and evolutionary learning reverses the order

  • Low severity
  • Not yet reviewed
  • Ordering reversal
  • Different tasks across studies

Zero-shot benchmarking of RNA language models in structural, functional, and evolutionary learning ranks Evo above Nucleotide Transformer v2 in 6 of 6 comparisons; other studies rank Nucleotide Transformer v2 above Evo in 42 of 45.

GENEB leaderboard ranks Nucleotide Transformer v2 above Evo in 42 of its 45 comparisons and Evo higher in 3. Zero-shot benchmarking of RNA language… ranks Evo above Nucleotide Transformer v2 in all 6 of its comparisons.

Comparisons in which each paper scores Nucleotide Transformer v2 or Evo higherGENEB leaderboard: Nucleotide Transformer v2 higher in 42, Evo higher in 3, 0 ties. Zero-shot benchmarking of RNA language… (disagrees): Nucleotide Transformer v2 higher in 0, Evo higher in 6, 0 ties.GENEB leaderboard42 Nucleotide Transformer v2 higher423 Evo higherDisagrees: Zero-shot benchmarking of RNA language…Zero-shot benchmarking of RNA language models in structural, functional, and evolutionary learning6 Evo higher6
Nucleotide Transformer v2 higherTieEvo higher
Compared
Nucleotide Transformer v2, Evo

Not reviewed yet.